# Cell Cycling Models of Carcinogenesis: A Complex Systems Analysis

**Authors:** V. I. Prisecaru, I. C. Baianu  
**arXiv:** [q-bio/0406046](https://arxiv.org/abs/q-bio/0406046)  
**Date:** 2004-06-24  
**Summary page:** https://www.summarizepaper.com/en/paper/q-bio--0406046v1/

## Key points

- The article proposes a new approach to analyzing the nonlinear dynamics involved in cell cycling network transformations during carcinogenesis.
- Carcinogenesis is complex and involves interconnected biomolecules across various compartments.
- Cell cyclins are proteins that link several critical pro-apoptotic and other cell cycling/division components.
- TP53, Thomsen-Friedenreich antigen (T antigen), Rb, mdm2, c-Myc, p21, p27, Bax, Bad and Bcl-2 all play major roles in neoplastic transformation of many tissues.
- The authors propose a novel theoretical analysis based on recently published studies of cyclin signaling with special emphasis placed on the roles of cyclins D1 and E.
- This analysis suggests potential clinical trials and rational therapies for cancer through reestablishment of cell cycling inhibition in metastatic cancer cells.
- The article provides valuable insights into the complex systems involved in carcinogenesis.

## Summary

The article "Cell Cycling Models of Carcinogenesis: A Complex Systems Analysis" proposes a new approach to analyzing the nonlinear dynamics involved in cell cycling network transformations during carcinogenesis. The process of carcinogenesis is complex and involves interconnected biomolecules across various compartments, including intercellular, membrane, cytosolic, nuclear, and nucleolar compartments that form numerous interrelated pathways. One such family of pathways includes the cell cyclins which are proteins that link several critical pro-apoptotic and other cell cycling/division components. These components include TP53 (tumor suppressor gene), Thomsen-Friedenreich antigen (T antigen), Rb, mdm2, c-Myc, p21, p27, Bax, Bad and Bcl-2 which all play major roles in neoplastic transformation of many tissues. The authors propose a novel theoretical analysis based on recently published studies of cyclin signaling with special emphasis placed on the roles of cyclins D1 and E. This analysis suggests potential clinical trials and rational therapies for cancer through reestablishment of cell cycling inhibition in metastatic cancer cells. Furthermore, this article provides valuable insights into the complex systems involved in carcinogenesis and offers promising avenues for developing effective treatments for cancer.